Key Features, Comprehensive and up-to-date coverage of the epidemiology, molecular pathogenesis, and cytogenetics of ALL, Extensive discussion of clinical trial data in childhood and adult ALL, Chapters devoted to in-depth coverage of key aspects of therapy including use of asparaginase, treatment of central nervous system ALL and management of long term secuelae, Detailed coverage of emerging areas including minimal residual disease monitoring and pharmacogenomics, Discussion of novel therapies including bispecific T-cell engaging antibody therapy and chimeric antigen receplor expressing T-cell therapy. Book jacket.
Product Identifiers
Publisher
Jaypee Brothers Medical Publishers
ISBN-10
9351522415
ISBN-13
9789351522416
eBay Product ID (ePID)
202521587
Product Key Features
Author
Vinod Pullarkat
Publication Name
Contemporary Management of Acute Lymphoblastic Leukemia
Format
Hardcover
Language
English
Publication Year
2014
Type
Textbook
Number of Pages
350 Pages
Dimensions
Item Length
9in
Item Width
6.5in
Item Weight
34.6 Oz
Additional Product Features
Lc Classification Number
Rc643
Table of Content
Contributors Foreword Preface Acknowledgments Chapter 1: Treatment of Acute Lymphoblastic Leukemia: A Historical Perspective Chapter 2: Epidemiology and Etiology of Acute Lymphoblastic Leukemia Chapter 3: Diagnosis and Classification of Acute Lymphoblastic Leukemia Chapter 4: Molecular Pathogenesis of Acute Lymphoblastic Leukemia Chapter 5: Cytogenetics of Acute Lymphoblastic Leukemia Chapter 6: Chemotherapy of Childhood Acute Lymphoblastic Leukemia Chapter 7: Chemotherapy of Adult Acute Lymphoblastic Leukemia Chapter 8: Use of Asparaginase in Acute Lymphoblastic Leukemia Chapter 9: Monitoring of Minimal Residual Disease to Guide Therapy of Acute Lymphoblastic Leukemia Chapter 10: Prophylaxis and Treatment of CNS Involvement in Acute Lymphoblastic Leukemia Chapter 11: Pharmacogenomics of Acute Lymphoblastic Leukemia Chemotherapy Chapter 12: Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia Chapter 13: Late Effects of Acute Lymphoblastic Leukemia Therapy Chapter 14: Novel Agents for the Treatment of Acute Lymphoblastic Leukemia